Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS

Beneficial Ownership Report · SCHEDULE 13D/A

Kardigan, Inc.

KARDNASDAQEQUITYCurrent

Beneficial Ownership Report

Filed Oct 1, 2026Accepted Oct 1, 2026, 4:35 PM EDTFiling CIK 2123613Accession 0001193125-26-410754
Share

Structured filing — SCHEDULE 13D/A

primary_doc.xml

Open full document ↗

Amendment · This filing reports the amendment as submitted.

Subject company

Company
Kardigan, Inc.
Company CIK
0002123613
Street
506 Carnegie Center Drive, Suite 201
City
Princeton
State / country code
NJ
Postal code
08540

Statement details

Amendment number
1
Security class
Common Stock, par value $0.00001 per share
Event date
09/29/2026
Previously filed indication
false

Authorized notification person 1

Name
Perceptive Advisors LLC
Phone
646-205-5345
Street
Alexander Rakitin, 51 Astor Place
Street (continued)
10th Floor
City
New York
State / country code
NY
Postal code
10003

Reporting person 1

Name
Perceptive Advisors LLC
Reporting person CIK
0001224962
No reporting person CIK indication
N
Citizenship / organization
DE
Reporting person type
IA
Group designation
b
Source of funds code
AF
Legal proceedings indication
Y
Aggregate amount owned
8,254,144
Percent of class
8.8
Sole voting power
0
Shared voting power
8,254,144
Sole dispositive power
0
Shared dispositive power
8,254,144
Aggregate excludes certain shares
N
Comments
The securities reported on this page consist of (i) 2,460,195 shares of Common Stock held directly by Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund"); (ii) 5,740,466 shares of Common Stock held directly by Perceptive Capital Solutions Holdings LP ("PCS Holdings"); and (iii) stock options issued to Douglas Giordano ("Mr. Giordano") in connection with his former service on the board of directors of Kardigan, Inc. (the "Issuer"), currently exercisable or exercisable within 60 days for 53,483 shares of Common Stock, with respect to which Perceptive Advisors LLC ("Perceptive Advisors") has the right to receive the director compensation provided in respect of Mr. Giordano's board service through a partial management fee offset. Perceptive Advisors serves as the investment manager to the Master Fund. Perceptive Capital Solutions Advisors LP ("PCS Advisors"), a relying adviser of Perceptive Advisors, serves as the investment manager to PCS Holdings, and Perceptive Capital Solutions GP LLC ("PCS GP") serves as the general partner of PCS Holdings. Joseph Edelman ("Mr. Edelman") is the managing member of each of Perceptive Advisors and PCS GP.

Reporting person 2

Name
Joseph Edelman
Reporting person CIK
0001164426
No reporting person CIK indication
N
Citizenship / organization
X1
Reporting person type
IN
Group designation
b
Source of funds code
AF
Legal proceedings indication
Y
Aggregate amount owned
8,254,144
Percent of class
8.8
Sole voting power
0
Shared voting power
8,254,144
Sole dispositive power
0
Shared dispositive power
8,254,144
Aggregate excludes certain shares
N
Comments
The securities reported on this page consist of (i) 2,460,195 shares of Common Stock held directly by the Master Fund (ii) 5,740,466 shares of Common Stock held directly by PCS Holdings; and (iii) stock options issued to Mr. Giordano in connection with his former service on the Issuer's board of directors, currently exercisable or exercisable within 60 days for 53,483 shares of Common Stock, with respect to which Perceptive Advisors has the right to receive the director compensation provided in respect of Mr. Giordano's board service through a partial management fee offset. Perceptive Advisors serves as the investment manager to the Master Fund. PCS Advisors, a relying adviser of Perceptive Advisors, serves as the investment manager to PCS Holdings, and PCS GP serves as the general partner of PCS Holdings. Mr. Edelman is the managing member of each of Perceptive Advisors and PCS GP.

Reporting person 3

Name
Perceptive Life Sciences Master Fund, Ltd.
Reporting person CIK
0001249675
No reporting person CIK indication
N
Citizenship / organization
E9
Reporting person type
CO
Group designation
b
Source of funds code
WC
Legal proceedings indication
Y
Aggregate amount owned
2,476,240
Percent of class
2.7
Sole voting power
0
Shared voting power
2,476,240
Sole dispositive power
0
Shared dispositive power
2,476,240
Aggregate excludes certain shares
N
Comments
The securities reported on this page consist of (i) 2,460,195 shares of Common Stock held directly by the Master Fund; and (ii) stock options issued to Mr. Giordano in connection with his former service on the Issuer's board of directors, currently exercisable or exercisable within 60 days for 16,045 shares of Common Stock, with respect to which Perceptive Advisors has the right to receive the director compensation provided in respect of Mr. Giordano's board service through a partial management fee offset. Perceptive Advisors serves as the investment manager to the Master Fund. Mr. Edelman is the managing member of Perceptive Advisors.

Reporting person 4

Name
Perceptive Capital Solutions Holdings LP
Reporting person CIK
0002142326
No reporting person CIK indication
N
Citizenship / organization
DE
Reporting person type
CO
Group designation
b
Source of funds code
WC
Legal proceedings indication
Y
Aggregate amount owned
5,777,904
Percent of class
6.2
Sole voting power
0
Shared voting power
5,777,904
Sole dispositive power
0
Shared dispositive power
5,777,904
Aggregate excludes certain shares
N
Comments
The securities reported on this page consist of (i) 5,740,466 shares of Common Stock held directly by PCS Holdings; and (ii) stock options issued to Mr. Giordano in connection with his former service on the Issuer's board of directors, currently exercisable or exercisable within 60 days for 37,438 shares of Common Stock, with respect to which Perceptive Advisors has the right to receive the director compensation provided in respect of Mr. Giordano's board service through a partial management fee offset. PCS Advisors, a relying adviser of Perceptive Advisors, serves as the investment manager to PCS Holdings, and PCS GP serves as the general partner of PCS Holdings. Mr. Edelman is the managing member of each of Perceptive Advisors and PCS GP.

Item 1

Issuer

Kardigan, Inc.

Security title

Common Stock, par value $0.00001 per share

Principal address

Item 4

Purpose of transaction

Item 4 of the Schedule 13D is amended and supplemented as followed: On September 29, 2026, Douglas Giordano, a Managing Director at Perceptive Advisors, resigned from the board of directors of the Issuer. The Reporting Persons continuously review their investment in the Issuer and, subject to applicable securities laws, regulatory requirements, and the lock-up agreement disclosed in the previously filed Schedule 13D, may from time to time acquire additional shares of Common Stock or other securities of the Issuer, hedge some or all of their economic exposure through short sales, options, swaps or other derivative or hedging transactions, or dispose of or distribute some or a significant amount of their Common Stock or other securities of the Issuer held or subsequently acquired, depending on various factors, including, but not limited to, the price of the shares, the terms and conditions of the transaction, prevailing market conditions, and their investment, liquidity and diversification objectives. Except as indicated herein, no Reporting Person, as a stockholder of the Issuer, has any plans or proposals that relate to or would result in any of the transactions or other matters specified in clauses (a) through (j) of Item 4 of Schedule 13D. Each Reporting Person may, at any time and from time to time, review or reconsider its or his position and/or change its or his purpose and/or formulate plans or proposals with respect thereto.

Item 5

Number of shares

The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated herein by reference.

Transactions

Except as otherwise disclosed in this Schedule 13D, none of the Reporting Persons has effected any transaction in the Common Stock during the past 60 days.

Other persons with an interest

Mr. Giordano is the holder of record of the stock options described herein. Perceptive Advisors has the right to receive the director compensation provided in respect of Mr. Giordano's former board service through a partial management fee offset.

Date ownership ceased to exceed 5%

Not applicable.

Percentage of class

The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentages set forth in row 13 are based on 93,503,699 shares of Common Stock outstanding, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 11, 2026, and assume the exercise of vested stock options issued to Mr. Giordano in connection with his former service on the Issuer's board of directors.

Signature 1

Reporting person
Perceptive Advisors LLC
Signed
/s/ Joseph Edelman
Title
Joseph Edelman, Managing Member
Date
10/01/2026

Signature 2

Reporting person
Joseph Edelman
Signed
/s/ Joseph Edelman
Title
Joseph Edelman
Date
10/01/2026

Signature 3

Reporting person
Perceptive Life Sciences Master Fund, Ltd.
Signed
/s/ Joseph Edelman
Title
Joseph Edelman, Managing Member
Date
10/01/2026

Signature 4

Reporting person
Perceptive Capital Solutions Holdings LP
Signed
/s/ Joseph Edelman
Title
Joseph Edelman, Managing Member
Date
10/01/2026

Company context

Kardigan is a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. Our mission is to develop multiple targeted cardiovascular treatments in parallel that bring people with cardiovascular diseases closer to the cures they deserve. We leverage deep domain expertise in cardiovascular biology, patient data, and advanced analytics to accelerate drug discovery and development, aiming to deliver impactful therapies efficiently and at scale.

Current securities

Recent company filings

  1. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureSep 30, 2026
  2. SCHEDULE 13G - filed by Edelberg Jay regarding Kardigan, Inc.Aug 13, 2026
  3. 10-Q filingAug 11, 2026
  4. Results of Operations and Financial ConditionAug 11, 2026
  5. 4 filingJun 24, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.